Mirati Therapeutics, Inc. is now part of Bristol Myers Squibb. Follow our progress delivering breakthrough therapies that target the genetic drivers of cancer @Bristol Myers Squibb or www.bms.com
View Top Employees from Mirati TherapeuticsWebsite | http://www.mirati.com |
Ticker | MRTX |
Revenue | $1 million |
Employees | 610 (610 on RocketReach) |
Founded | 2013 |
Address | 3545 Cray Ct, San Diego, California 92121, US |
Phone | (858) 332-3410 |
Industry | Biotechnology Research, Pharmaceuticals, Healthcare |
Web Rank | 3 Million |
Keywords | Clinical-Stage Biotechnology Company, Cancer Therapeutics, Unmet Medical Needs, Targeted Cancer Therapies, Precision Medicine |
Competitors | Celldex Therapeutics, G1 Therapeutics, Inc., Mersana Therapeutics, ORIC Pharmaceuticals Inc., Sorrento Therapeutics, Inc. |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541712 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 33 Companies, NAICS Code 54171 Companies |
Looking for a particular Mirati Therapeutics employee's phone or email?
The Mirati Therapeutics annual revenue was $1 million in 2024.
Aaron Ondrey is the Chief Financial Officer (interim) of Mirati Therapeutics.
610 people are employed at Mirati Therapeutics.
Mirati Therapeutics is based in San Diego, California.
The NAICS codes for Mirati Therapeutics are [541712, 541, 5417, 54, 33, 54171].
The SIC codes for Mirati Therapeutics are [873, 87].